AN ANTI-ANGIOGENIC KRINGLE PROTEIN AND ITS MUTANTS

摘要

There is provided a pharmaceutical composition including at least one kringle protein and a pharmaceutically acceptable carrier. Also provided by the present invention is a method of treating a disease by administering an effective amount of a compound from the group consisting of kringle proteins, KED and a kringle derived from the tPA protein.